TABLE III.
Treatments and Outcomes for Children With Respiratory Syncytial Virus (RSV) or Seasonal Influenza and Sickle Cell Disease (SCD), Johns Hopkins Hospital 1993–2011
Variable | RSV n = 64 | Influenza n = 91 |
P-Value |
---|---|---|---|
Acute chest syndrome | 26% (15/58) | 15% (13/84) | 0.13 |
Hospital admission | 100% | 89% | 0.006 |
Intensive care | 5% | 3% | 0.69 |
Ventilatory support | 5% | 0% | 0.07 |
Acute transfusion PRBC* | 13% | 15% | 0.65 |
Therapy with antiviral agents | 5% | 40% | <0.0001 |
Therapy with antibacterial agents | 100% | 97% | 0.27 |
Therapy with bronchodilators | 50% | 40% | 0.25 |
Length of stay (days)** | 2 (1–3) | 2 (1–3) | 0.15 |
Hospital charges ($)** | 4,599 (3,352, 6,424) | 4,603 (3,117, 6,695) | 0.54 |
Indicates packed red blood cells.
Indicates median (interquartile range).